B

Britannia Life Sciences Inc
CNSX:BLAB

Watchlist Manager
Britannia Life Sciences Inc
CNSX:BLAB
Watchlist
Price: 0.08 CAD 6.67% Market Closed
Market Cap: 13m CAD

Operating Margin

-53.4%
Current
Declining
by 32%
vs 3-y average of -21.4%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-53.4%
=
Operating Income
CA$-1.1m
/
Revenue
CA$2.1m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-53.4%
=
Operating Income
CA$-1.1m
/
Revenue
CA$2.1m

Market Distribution

In line with most companies in Canada
Percentile
32st
Based on 4 855 companies
32st percentile
-53.4%
Low
-4 710 029.9% — -65.8%
Typical Range
-65.8% — 11%
High
11% — 71 100%
Distribution Statistics
Canada
Min -4 710 029.9%
30th Percentile -65.8%
Median -2.4%
70th Percentile 11%
Max 71 100%

Britannia Life Sciences Inc
Glance View

Market Cap
13m CAD
Industry
N/A

Britannia Life Sciences, Inc. is a global product development platform. The company is headquartered in Toronto, Ontario. The company went IPO on 2017-12-01. The firm's platform offers an integrated suite of services to assist companies along their product development journey. The firm provides product formulations, safety assessments, analytical and microbiological testing, global compliance and consumer evaluations to the cosmetic, consumer packaged goods and nutraceutical industries in the United Kingdom and globally. The company is also engaged in the development and regulatory approval of topical and edible cannabis products, including preparation and support for food authorizations. The company serves consumer packaged goods (CPG), cosmetics, household goods and nutraceutical industries, blue-chip, food and beverage, nutraceutical sectors, toiletries, small and medium enterprise (SME) clients.

BLAB Intrinsic Value
0.06 CAD
Overvaluation 30%
Intrinsic Value
Price
B
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-53.4%
=
Operating Income
CA$-1.1m
/
Revenue
CA$2.1m
What is Britannia Life Sciences Inc's current Operating Margin?

The current Operating Margin for Britannia Life Sciences Inc is -53.4%, which is below its 3-year median of -21.4%.

How has Operating Margin changed over time?

Over the last 3 years, Britannia Life Sciences Inc’s Operating Margin has increased from -147.2% to -53.4%. During this period, it reached a low of -299.6% on Mar 31, 2024 and a high of 22.4% on Jun 30, 2023.

Back to Top